Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-01-02 @ 2:00 AM
Study NCT ID:
NCT04139304
Status:
RECRUITING
Last Update Posted:
2025-06-29
First Post:
2019-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Sponsor:
AIDS Malignancy Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-24
Start Date Type:
ACTUAL
Primary Completion Date:
2029-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-22
First Submit QC Date:
None
Study First Post Date:
2019-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-26
Last Update Post Date:
2025-06-29
Last Update Post Date Type:
ACTUAL